Search Results

Filter
  • 1-10 of  55,601 results for ""Cyclosporine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cyclosporine A-induced systemic metabolic perturbations in rats: A comprehensive metabolome analysis.

  • Authors : Yen NTH; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Republic of Korea.; Tien NTN

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/toxicity ; Cyclosporine*/Cyclosporine*/Cyclosporine*/metabolism ; Cholestasis*/Cholestasis*/Cholestasis*/chemically induced

  • Source: Toxicology letters [Toxicol Lett] 2024 May 01; Vol. 395, pp. 50-59. Date of Electronic Publication: 2024 Mar 28.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7709027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment.

  • Authors : Hao T; Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.; Tang L

Subjects: Fibroins*/Fibroins*/Fibroins*/chemistry ; Cyclosporine*/Cyclosporine*/Cyclosporine*/administration & dosage ; Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacokinetics

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Apr 29; Vol. 25 (5), pp. 92. Date of Electronic Publication: 2024 Apr 29.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

×
Academic Journal

Cyclosporine a inhibits bone regeneration and induces bone loss in a rat model.

  • Authors : Tao ZS; Department of Orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe Shan Xi Road, Wuhu 241001, Anhui, PR China; Anhui Province Key Laboratory of Non-coding RNA Basic and Clinical Transformation, No. 2, Zhe Shan Xi Road, Wuhu 241001, Anhui, PR China. Electronic address: .

Subjects: Bone Regeneration*/Bone Regeneration*/Bone Regeneration*/drug effects ; Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; Osteogenesis*/Osteogenesis*/Osteogenesis*/drug effects

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 10; Vol. 132, pp. 111951. Date of Electronic Publication: 2024 Mar 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mitochondrial SIRT3 as a protective factor against cyclosporine A-induced nephrotoxicity.

  • Authors : Kim JE; Department of Internal Medicine, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul, 08308, South Korea.; Jo MJ

Subjects: Sirtuin 3*/Sirtuin 3*/Sirtuin 3*/metabolism ; Sirtuin 3*/Sirtuin 3*/Sirtuin 3*/genetics ; Cyclosporine*/Cyclosporine*/Cyclosporine*/adverse effects

  • Source: Scientific reports [Sci Rep] 2024 May 02; Vol. 14 (1), pp. 10143. Date of Electronic Publication: 2024 May 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of Extraction Procedure Substitution on Automated Tacrolimus, Sirolimus, and Cyclosporine Assays.

  • Authors : Chandras A; Department of Pathology, Molecular & Cell Based Medicine, Mount Sinai Hospital, New York, NY, United States.; Mendu DR

Subjects: Tacrolimus*/Tacrolimus*/Tacrolimus*/blood ; Tacrolimus*/Tacrolimus*/Tacrolimus*/analysis ; Sirolimus*/Sirolimus*/Sirolimus*/blood

  • Source: The journal of applied laboratory medicine [J Appl Lab Med] 2024 May 02; Vol. 9 (3), pp. 573-578.Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print Cited Medium: Print ISSN: 2576-9456

Record details

×
Academic Journal

Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).

  • Authors : García MJ; Gastroenterology and Hepatology Department, Hospital Universitario Marqués de Valdecilla, Grupo de Investigación Clínica y Traslacional en Enfermedades Digestivas, Instituto de Investigación Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.; Riestra S

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/surgery ; Infliximab*/Infliximab*/Infliximab*/therapeutic use

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 May; Vol. 59 (10), pp. 1248-1259. Date of Electronic Publication: 2024 Mar 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.

  • Authors : Nikoloudis A; Department of Internal Medicine I: Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz - Elisabethinen, Linz, Austria; Medical Faculty, Johannes Kepler University, Linz, Austria. Electronic address: .

Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/drug therapy ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

  • Source: Cytotherapy [Cytotherapy] 2024 May; Vol. 26 (5), pp. 490-497. Date of Electronic Publication: 2024 Feb 15.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566

Record details

×
Academic Journal

Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation.

  • Authors : Salas MQ; University of Toronto, Department of Medicine, Section of Medical Oncology and Hematology, Toronto, Ontario, Canada; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Subjects: Antilymphocyte Serum*/Antilymphocyte Serum*/Antilymphocyte Serum*/therapeutic use ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control

  • Source: Transplantation and cellular therapy [Transplant Cell Ther] 2024 May; Vol. 30 (5), pp. 536.e1-536.e13. Date of Electronic Publication: 2024 Jan 27.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement.

Subjects: Rhabdomyolysis*/Rhabdomyolysis*/Rhabdomyolysis*/chemically induced ; Kidney Transplantation* ; Drug Interactions*

  • Source: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 May-Jun; Vol. 64 (3), pp. 102016. Date of Electronic Publication: 2024 Jan 23.Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy of combined low-dose ruxolitinib and cyclosporine in murine immune bone marrow failure.

  • Authors : Feng X; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. .; Manley AL

Subjects: Nitriles* ; Pyrazoles*/Pyrazoles*/Pyrazoles*/therapeutic use ; Pyrazoles*/Pyrazoles*/Pyrazoles*/administration & dosage

  • Source: Haematologica [Haematologica] 2024 May 01; Vol. 109 (5), pp. 1603-1607. Date of Electronic Publication: 2024 May 01.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  55,601 results for ""Cyclosporine""